These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31489677)

  • 1. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
    Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
    Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A
    English CJ; Lohning AE; Mayr HL; Jones M; Reidlinger DP
    Biofactors; 2023 Mar; 49(2):457-471. PubMed ID: 36538603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
    da Silva IT; Timm Ade S; Damasceno NR
    Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.
    Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG
    Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
    Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
    Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.
    Brilakis ES; Khera A; McGuire DK; See R; Banerjee S; Murphy SA; de Lemos JA
    Atherosclerosis; 2008 Jul; 199(1):110-5. PubMed ID: 18061193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between lipoprotein associated phospholipase A
    Chen YH; Li WC; Chen YC; Yeh WC; Yu W; Hung HY; Jie XX; Chen JY
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048562. PubMed ID: 34796753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.
    Wootton PT; Stephens JW; Hurel SJ; Durand H; Cooper J; Ninio E; Humphries SE; Talmud PJ
    Atherosclerosis; 2006 Nov; 189(1):149-56. PubMed ID: 16438975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study.
    Folsom AR; Lutsey PL; Roetker NS; Ballantyne CM; Hoogeveen RC; Rosamond WD; Cushman M;
    Thromb Res; 2013 Jul; 132(1):44-6. PubMed ID: 23746626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
    Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
    Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
    Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
    Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.
    Rosing K; Fobker M; Kannenberg F; Gunia S; Dell'Aquila AM; Kwiecien R; Stypmann J; Nofer JR
    Atherosclerosis; 2013 Sep; 230(1):164-70. PubMed ID: 23958269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
    Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
    J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.